NCT00931541View on ClinicalTrials.gov

AZD6088 Single Ascending Dose Study

PHASE1CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

June 30, 2009

Study Completion Date

August 31, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

AZD6088

Oral solution. Each subject will receive a single-dose of AZD6088.

DRUG

Placebo

Oral solution. Each subject will receive a single-dose of placebo.

Trial Locations (1)

Unknown

Research Site, London Bridge

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY